Skip to content
Clinical Trial Events
19th Clinical Trials on Alzheimer's Disease (CTAD) 2026

Talk

Oral Communications

Thu, Nov 19, 2026 · 11:05 AM–12:05 PM EST Ballroom - 4th floor, Boston Marriott Copley Place

About this session

Oral communications: OC44 The relationship between P-tau217 blood tests and neuropathology at autopsy in cognitively unimpaired individuals; OC45 When Is Amyloid Really Cleared? Discordance Between Centiloid Quantification and Visual Reads after Treatment; OC46 Cognitive change across the healthy adult lifespan, ages 36 to 108: Associations with modifiable risk factors and ADRD plasma biomarkers; OC47 PROTECT-Cog: A Large, Global Randomized Phase 3 Trial of Combined Multidomain Lifestyle Intervention With and Without a Metabolic Targeting Drug to Benefit Cognitive Performance and Mitigate Decline in At-Risk Older Adults.

Speakers